Devicare has obtained the patent in Spain for a new electrochemical ion sensor, which is the most advanced of its type on the market, improving the features of the Lit-Control pH Meter® medical device for self-monitoring chronic urological diseases (lithiasis, infections, overactive bladder, calcification of urinary catheters, etc.). Specifically, the sensor incorporates a reference electrode that prevents it from drying after its use.
LELR-AEU 2018 Meeting report Advances in the treatment and medical management of lithiasis, which affects 15% of Spain’s population and is increasing considerably, namely renal lithiasis, were the focus of the 28th National Meeting of the Groups of Lithiasis, Endourology, Laparoscopy and Robotics organized by the Spanish Association of Urology on January 25 and 26 in Cordoba.
Devicare has signed a participative loan worth 2 million Euros from the Innova Global line by Avançsa, assigned to the Business and Expertise Department, with the option to convert the investment into Series A stock in the mid-term. With this new economic injection, Devicare will continue the strategic development and validation plan of new medical solutions under the Remote Patient Monitoring concept...
Devicare has been one of the companies invited to the Lessons Learned held by the CataloniaBio and Biocat business association on 29 November in Barcelona to explain its business strategy and the lessons it has learned since it was founded in 2012. The debate centred on the convergence between the biopharmaceutical and MedTech sectors to contribute innovative and effective solutions to the world's most prominent diseases.
The Cerdanyola Empresarial gala took place yesterday in the Hotel of the Autonomous University of Barcelona, where Devicare collected the Prize for Research and innovation 2017 for its work in developing medical devices and solutions and remote patient monitoring. Rosendo Garganta, founder and CEO of Devicare, received the award from the president of the Entrepreneurs Association Lluís Sisquella.
Barcelona's Hospital Delfos will implement a healthcare improvement plan based on home-based self-monitoring for patients to reduce the recurrence of chronic urological diseases such as renal and urinary lithiasis (kidney or bladder stones) and urinary infections, among others. This will also help strengthen patients' proactive participation in the clinical decisions that directly affect them.
34.3% of Catalans suffer from a chronic disease. Mental disorders are one of the most prevalent diseases and also have a major functional impact on the individuals. Individuals who suffer mental illnesses need frequent check-ups to optimize treatment, prevent relapses and improve adherence.
Sensors are changing our lives, also in healthcare (for the better). During the opening ceremony of the Healthcare and Social ICT R+D+I Conference held in the University of Vic on 28 September, Marina Geli, coordinator of the Healthcare and Social Studies Centre (CESS), highlighted that sensor technology is essential to advance patient empowerment in the home.
This week Vienna is hosting the largest European Urolithiasis Meeting, organised every two years by the European Association of Urology (EAU). The event will bring together opinion leaders and experts who will present the latest international scientific advances to improve the treatment of this disease.
Devicare has revamped the websites for their two medical solutions that are unique on the market (first-in-class): Tao-Control® for chronic anticoagulated patients and the Lit-Control® product line for urinary health.
Board Member and Private Investor in different biotech start-ups.
Former President of Medical Devices Committee at Catalonia Association of Biotech Companies.
Master in Business Administration.
Master in International Business.
Master in Entrepreneurship & Innovation.
BSc. Industrial Engineering.
BSc. Electronic Engineering.
+10 years of experience in Business Development in MD companies.
